Eric Sievers, Chief Medical Officer at BioAtla, Inc. (BCAB), sold 1,124 shares at $25.38 ($25K) on 2021-11-30, disclosed to the SEC on 2021-12-07.
Open-market sale of $25k BCAB by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 53 | $1K | 5.1% |
| 2 | $24.68 | 58 | $1K | 5.7% |
| 3 | $25.38 | 20 | $508 | 2.0% |
| 4 | $22.19 | 56 | $1K | 5.0% |
| 5 | $23.27 | 96 | $2K | 8.9% |
| 6 | $24.22 | 21 |
| $509 |
| 2.0% |
| 7 | $21.74 | 804 | $17K | 69.8% |
| 8 | $22.47 | 16 | $360 | 1.4% |
| Total | $22.27 avg | 1,124 | $25K | 100% |
| Filing → |
| BCAB | SELL | 2021-10-07 | $18K | — | Filing → |
| BCAB | SELL | 2021-08-30 | $545K | — | Filing → |